Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

166 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Completed

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

NCT04965597

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +31 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital/UCSD San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

NCT05630001

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • City Of Hope National Med Center Duarte, California, United States
  • USC Norris Cancer Center Los Angeles, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • Mass Gen Hosp Cancer Center Boston, Massachusetts, United States
View all 23 locations
View Trial Details
Completed

Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to Ravulizumab

NCT05972967

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Omeros Investigational Site Aachen, Germany
  • Omeros Investigational Site Ulm, Germany
  • Omeros Investigational Site Thessaloniki, Greece
  • Omeros Investigational Site Lausanne, Switzerland
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

NCT06593938

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Blood Disease Hospital of the Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details

Related conditions